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In many fields of medical research there is an increasing attention to the role of sex and 
gender differences in healthcare. Sex refers to the biological differences between men 
and women, whereas gender refers to attitudes and behaviours which could be either 
masculine or feminine (1). 
Sex and gender research in the field of type 2 diabetes (T2D) showed that the negative 
impact of type 2 diabetes on different healthcare outcomes might be higher among women 
compared to men (2). However, whether this phenomenon holds true for the Dutch T2D 
population is yet unknown. It is hypothesized to be a combination of physiological, 
psychological, sociological and health-related factors that result in differences between 
men and women with T2D. Many of these factors differ between countries and cultures. 
The aim of this thesis was therefore to investigate sex and gender differences in diabetes 
care for patients treated in primary care in the Netherlands. 
In this thesis, ‘sex’ is used to describe differences between men and women which are 
considered to be mainly caused by biological differences, and ‘gender’ is used to indicate 
differences which are considered to be mainly caused by psychological and behavioural 
differences. A large part of this thesis is based on the ZODIAC cohort, which consists of 
patients with T2D who are treated in primary care. Data of this cohort have been used to 
describe the treatment and control of cardiovascular risk factors in different years for men 
and women, and to describe the survival of men and women with T2D in primary care. 
The ZODIAC cohort has also been linked to the Netherlands Cancer Registry (NKR). 
Data of this linkage have been used to assess cancer incidence and risk of obesity-related 
cancers. Gender differences in patient activation, well-being and patients’ evaluation of 
care have been assessed in cross-sectional studies based on the ZODIAC cohort. The 
results of the different chapters of this thesis will be summarized below. 
Part 1 Sex differences 
In chapter 2, sex differences in control of cardiovascular risk factors were reported 
for patients with T2D treated in primary care from 1998 to 2013. This study showed a 
considerable improvement in quality of care for both men and women with T2D, yet 
a few sex differences were found. Potentially relevant sex differences in improvement 
of care were observed for HbA1c, systolic blood pressure, BMI and smoking, whereby 
the differences between sexes converged throughout the study period. At the end of 
the study period, men were less frequently obese compared to women. Furthermore, 
men over 75 years of age had a lower blood pressure. In contrast, women had better 








































166  |  Chapter 10
For HbA1c no difference between sexes was observed anymore in the final 9 years. 
Overall, cardiovascular risk factors were not relevantly poorer controlled in either men 
or women with T2D. 
The survival of T2D patients relative to the general population in the Netherlands was 
investigated in chapter 3. After 14 years of follow-up, relative survival for patients with 
T2D who were treated in primary care was 12% lower in men and 18% lower in women 
compared to age-matched men and women in the general population. This corresponds 
with a median survival that was 2.2 years lower in men and 3.5 years lower in women 
with T2D compared to men and women in the general population. Although the impact 
of T2D on survival seemed to be higher in women, no significant difference was found 
between sexes in the total study population. Only in patients with T2D without a history 
of cardiovascular disease a significant lower relative survival of women compared to 
men was found. 
In chapter 4, cancer incidence of men and women with T2D was compared with the cancer 
incidence of men and women in the general population in the Netherlands in the periods 
5 years before, around and 5 years after the diagnosis of diabetes. The results showed 
that cancer incidence peaked around diabetes diagnosis in both men and women. This 
peak in cancer incidence could probably be explained by increased detection as a result 
of additional attention, care, and diagnostic tests at the time of diabetes diagnosis. Clear 
sex differences were found. In men, an increase in incidence of cancer was found around 
diabetes diagnosis and in the period 5 years after diagnosis. In women, this higher 
incidence was also present as early as 5 years before diabetes diagnosis. The latter might 
be attributable to a higher incidence of breast cancer. Postmenopausal breast cancer is 
considered to be related to obesity (3). It is plausible that women put on weight prior to 
diabetes diagnosis. This may result in a higher occurrence and detection rate of breast 
cancer in screening programs prior to diabetes diagnosis in these women. 
In chapter 5, the association between BMI and obesity-related cancers was investigated in 
both men and women with T2D. Results showed that BMI was positively associated with 
obesity-related cancers in men with T2D, with the exception of advanced prostate cancer. 
In women with T2D, BMI was associated with the total group of obesity-related cancers 
and with ovarian, endometrial and postmenopausal breast cancer. No association was 
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Part 2 Gender differences 
In chapter 6 the relationship between lifestyle factors and emotional well-being in men 
and women with T2D was described. A positive relationship between physical activity 
and emotional well-being in both men and women was identified. Also, a negative 
relationship between smoking and emotional well-being was found in the total study 
population with T2D. However, the clinical relevance of both associations appears to be 
very limited. 
Chapter 7 focused on gender differences in the degree of patient activation which is 
defined as the confidence, knowledge and skills which are needed for self-management. 
Between men and women with T2D, the degree of patient activation did not differ. 
Therefore, there is no justification for approaching men and woman differently with 
regard to the level of self-management tasks.
The results of chapter 8 showed that there were some gender differences in patient-related 
factors which were associated with patients’ evaluation of care of men and women with 
T2D in primary care. Nevertheless, the degree to which these factors together could 
explain the patients’ evaluation of care was very low in both sexes. Therefore, in attempts 
to improve patients’ evaluation of care, no different approach for men and women with 
T2D seems to be needed.
In this thesis, small sex and gender differences in several aspects of T2D were identified. 
However, the majority of these differences have probably no consequences for daily 
practice. Only sex differences in smoking prevalence, obesity and sex-specific cancer 
incidence need further attention. Except these aspects, it can be concluded that it is not 
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